Falise v. American Tobacco Co.

107 F. Supp. 2d 200, 2000 WL 1041325
District Court, E.D. New York·Decided July 28, 2000·No. CV99-7392·Published·Cited by 12 cases

Opinion

PRELIMINARY MEMORANDUM & ORDER

WEINSTEIN, Senior District Judge.

Continuing the court’s decisions on in limine motions reflected in orders dated July 18, 19, and 25, the parties’ first Dau-bert motions are now addressed:

Expert Witnesses Challenged

There have been a number of challenges to the testimony of the following experts proposed as witnesses in the forthcoming trial:

1. Dr. Jeffrey Harris will appear for plaintiffs to testify on the relationship between Tobacco conduct and Trust claimant smoking patterns, disease causation and resulting injury to claimants. Dr. Harris’s proposed model purports to demonstrate that those exposed to asbestos would have quit smoking earlier if they had not been mislead by Tobacco’s fraud, thus leading to less serious diseases to be compensated by the Trust.
2. Dr. Thomas Florence is proffered by plaintiffs to forecast future claims. He has been unable to appear at a required evidentiary hearing. The Daubert hearing on this witness is postponed. The parties will arrange promptly with the case coordinator, Ms. June Lowe, for an evidentiary Daubert hearing or submit the issue on papers.
3. Professor Jon D. Hanson is a proposed witness for plaintiffs to discuss the impact of Tobacco conduct, particularly advertising, on smoking patterns and consumer behavior. A pri-ma facie demonstration of compliance with Rule 702 of the Federal Rules of Evidence has been established by copies of his articles now on file. If the parties wish an evidentiary Daubert hearing on this witness they should arrange for one promptly with the case coordinator.
4. Professor Peter Schuck’s testimony was offered by defendants on the following: the impact of Trust settlement policies and practices; the Trust’s inability to demonstrate that any of the dollars paid by the Trust historically were due to conduct of the Tobacco industry; and the impact of mass tort dynamics on Trust settlement decisions, negotiation of the Trust Distribution Process agreement (TDP) and dollars ultimately paid.
5. Dr. Frederick Dunbar is to appear for defendants to rebut Dr. Harris’s testimony by arguing that Trust cost-benefit calculations in settling claims, not decisions anchored in tort law, explain Trust payments. He has also provided a model demonstrating that even had the Tobacco industry not mislead Trust claimants, the amounts payable by the Trust would have been the same.
6. Professor Karen Gross has offered to testify for defendants on the impact of Johns-Manville’s plan of reorganization, and on policies adopted by the Trust for settlement of asbestos claims and dollars paid by the Trust over time.
7. Professor William O’Connell’s testimony is proposed by defendants on the Trust’s operation and its impact on dollars expended.

Each of these experts is highly qualified in his or her field.

For the reasons stated orally on the record, the testimony of the following appear to be unnecessary and are excluded pursuant to the court’s general authority to control the trial and on the assumption that the documents they would have relied on can be utilized in arguments by counsel: Professor Peter Schuck, Professor Karen Gross, and Professor William O’Connell. No Daubert decisions as to these three experts are required. During the course *203 of trial, the parties may request the court to reconsider its decision.

Criteria for Exercising Court’s Daubert Role

The trial court is not called upon to analyze in great detail the proposed testimony of an expert as part of the Daubert hearing-although at times it may be useful to do so as in connection with problems of proving general causation in the first cases on the subject of harm caused by a pharmaceutical product. Requiring a detailed analysis for such in limine matters tends to slow down the litigation and make it more burdensome to the parties and the courts. While, unlike the jury, the court is expected to give reasons for its decisions, particularly after trial, a brief summary is all that is required under Rules 104 and 702 of the Federal Rules of Evidence for these Daubert hearings.

Daubert Analysis for Doctors Harris and Dunbar

Full evidentiary hearings were held with respect to Dr. Harris and Dr. Dunbar. Both are by education and experience fully qualified in the fields they propose to address. Both are well recognized with extensive reliable peer reviewed publications and prior court testimony. Both propose to submit statistical models based upon their own research, recognized research of others, peer reviewed publications, and information properly relied upon by experts such as themselves for similar purposes.

The court evaluates Dr. Harris’s and Dr. Dunbar’s testimony, and their respective underlying models, for gatekeep-ing purposes under Rule 702 of the Federal Rules of Evidence as amended effective December 1, 2000. See also, e.g., Kumho Tire Co. v. Carmichael, 526 U.S. 137, 119 S.Ct. 1167, 143 L.Ed.2d 238 (1999); Daubert v. Merrell Doiv Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). The amended rule reads as follows:

If scientific, technical, or other specialized knowledge will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified as an expert by knowledge, skill, experience, training, or education, may testify thereto in the form of an opinion or otherwise, if (1) the testimony is based wpon sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case.

Fed.R.Evid. 702 (as amended Dec. 1, 2000) (amended text emphasized). The admissibility of expert testimony is predicated upon convincing the court pursuant to Rule 104(a) that the proponent has established scientific reliability by a preponderance of the evidence.

The specific Daubert criteria identified by the Supreme Court have been considered and the court has found these factors established for both Dr. Harris and Dr. Dunbar. As summarized by the Advisory Committee Note to the amended Rule, these factors are:

Free access — add to your briefcase to read the full text and ask questions with AI

Falise v. American Tobacco Co., 107 F. Supp. 2d 200, 2000 WL 1041325 (E.D.N.Y. 2000).

107 F. Supp. 2d 200 (Falise v. American Tobacco Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related